328 related articles for article (PubMed ID: 12565992)
1. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
2. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.
Webley SD; Welsh SJ; Jackman AL; Aherne GW
Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279
[TBL] [Abstract][Full Text] [Related]
3. Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331.
Webley SD; Hardcastle A; Ladner RD; Jackman AL; Aherne GW
Br J Cancer; 2000 Sep; 83(6):792-9. PubMed ID: 10952785
[TBL] [Abstract][Full Text] [Related]
4. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
Ladner RD
Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
[TBL] [Abstract][Full Text] [Related]
5. 5-chloro-2'-deoxyuridine cytotoxicity results from base excision repair of uracil subsequent to thymidylate synthase inhibition.
Brandon ML; Mi L; Chaung W; Teebor G; Boorstein RJ
Mutat Res; 2000 Mar; 459(2):161-9. PubMed ID: 10725666
[TBL] [Abstract][Full Text] [Related]
6. Analysis of uracil DNA glycosylase in human colorectal cancer.
Dusseau C; Murray GI; Keenan RA; O'Kelly T; Krokan HE; McLeod HL
Int J Oncol; 2001 Feb; 18(2):393-9. PubMed ID: 11172609
[TBL] [Abstract][Full Text] [Related]
7. Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.
Luo Y; Walla M; Wyatt MD
DNA Repair (Amst); 2008 Feb; 7(2):162-9. PubMed ID: 17942376
[TBL] [Abstract][Full Text] [Related]
8. Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency.
Li L; Connor EE; Berger SH; Wyatt MD
Biochem Pharmacol; 2005 Nov; 70(10):1458-68. PubMed ID: 16191427
[TBL] [Abstract][Full Text] [Related]
9. dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae.
Tinkelenberg BA; Hansbury MJ; Ladner RD
Cancer Res; 2002 Sep; 62(17):4909-15. PubMed ID: 12208740
[TBL] [Abstract][Full Text] [Related]
10. Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.
Grogan BC; Parker JB; Guminski AF; Stivers JT
Biochemistry; 2011 Feb; 50(5):618-27. PubMed ID: 21222484
[TBL] [Abstract][Full Text] [Related]
11. Involvement of base excision repair in response to therapy targeted at thymidylate synthase.
Li L; Berger SH; Wyatt MD
Mol Cancer Ther; 2004 Jun; 3(6):747-53. PubMed ID: 15210861
[TBL] [Abstract][Full Text] [Related]
12. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.
Van Triest B; Pinedo HM; Giaccone G; Peters GJ
Ann Oncol; 2000 Apr; 11(4):385-91. PubMed ID: 10847455
[TBL] [Abstract][Full Text] [Related]
13. Measurement of deoxyuridine triphosphate and thymidine triphosphate in the extracts of thymidylate synthase-inhibited cells using a modified DNA polymerase assay.
Horowitz RW; Zhang H; Schwartz EL; Ladner RD; Wadler S
Biochem Pharmacol; 1997 Sep; 54(5):635-8. PubMed ID: 9337081
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
15. Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.
Welsh SJ; Titley J; Brunton L; Valenti M; Monaghan P; Jackman AL; Aherne GW
Clin Cancer Res; 2000 Jun; 6(6):2538-46. PubMed ID: 10873110
[TBL] [Abstract][Full Text] [Related]
16. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage.
Yan Y; Han X; Qing Y; Condie AG; Gorityala S; Yang S; Xu Y; Zhang Y; Gerson SL
Oncotarget; 2016 Sep; 7(37):59299-59313. PubMed ID: 27517750
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer.
Wilson PM; LaBonte MJ; Lenz HJ; Mack PC; Ladner RD
Mol Cancer Ther; 2012 Mar; 11(3):616-28. PubMed ID: 22172489
[TBL] [Abstract][Full Text] [Related]
19. Thermostable uracil-DNA glycosylase from Thermotoga maritima a member of a novel class of DNA repair enzymes.
Sandigursky M; Franklin WA
Curr Biol; 1999 May; 9(10):531-4. PubMed ID: 10339434
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
Curtin NJ; Harris AL; Aherne GW
Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
